Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Drijfhout

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Immunology|May 6, 1999
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaM E Ressing, J H de Jong, R M Brandt, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
The Journal of Infectious Diseases|January 1, 1994
Identification of an antigenic domain on Mycobacterium leprae protein antigen 85B, which is specifically recognized by antibodies from patients with leprosyE Filley, J E Thole, G A Rook, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cellsR E Toes, E I van der Voort, S P Schoenberger, et al.
Leukemia|October 17, 2003
Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cellsE H A Spaenij-Dekking, J Van Delft, E Van Der Meijden, et al.
European Journal of Immunology|September 1, 1993
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsM C Feltkamp, H L Smits, M P Vierboom, et al.
Journal of Neuroimmunology|May 4, 2019
H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controlsM S Schinkelshoek, R Fronczek, E M C Kooy-Winkelaar, et al.
Molecular Microbiology|July 1, 1992
Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groEST F Rinke de Wit, S Bekelie, A Osland, et al.
Cancer Letters|June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposesC J Vennegoor, H W Nijman, J W Drijfhout, et al.
European Journal of Immunology|September 1, 1993
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53J G Houbiers, H W Nijman, S H van der Burg, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Immunology|May 6, 1999
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaM E Ressing, J H de Jong, R M Brandt, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
The Journal of Infectious Diseases|January 1, 1994
Identification of an antigenic domain on Mycobacterium leprae protein antigen 85B, which is specifically recognized by antibodies from patients with leprosyE Filley, J E Thole, G A Rook, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cellsR E Toes, E I van der Voort, S P Schoenberger, et al.
Leukemia|October 17, 2003
Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cellsE H A Spaenij-Dekking, J Van Delft, E Van Der Meijden, et al.
European Journal of Immunology|September 1, 1993
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cellsM C Feltkamp, H L Smits, M P Vierboom, et al.
Journal of Neuroimmunology|May 4, 2019
H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controlsM S Schinkelshoek, R Fronczek, E M C Kooy-Winkelaar, et al.
Molecular Microbiology|July 1, 1992
Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groEST F Rinke de Wit, S Bekelie, A Osland, et al.
Cancer Letters|June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposesC J Vennegoor, H W Nijman, J W Drijfhout, et al.
European Journal of Immunology|September 1, 1993
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53J G Houbiers, H W Nijman, S H van der Burg, et al.
Pageof 10